Barclays Upgrades Vector Group to Overweight, Raises Price Target to $16
Barclays analyst Gaurav Jain upgrades Vector Group (NYSE:VGR) from Equal-Weight to Overweight and raises the price target from $12 to $16.
Insider Weekends: ICONIQ Adds To Its Stake In Construction Management Software Company Procore Technologies + Notable Insider Trades
The huge drop we saw in most markets earlier this week triggered a large number of insider purchases and it was interesting to watch both the S&P 500 and the Nasdaq close in positive territory for the week.
Sunday Is Your Last Chance To Buy Vector Group Before The Dividend Payout
Sunday marks the last chance for investors to receive the next dividend payout from Vector Group (NYSE:VGR).
UPDATE: Vector Group Q4 Adj. EPS $0.26 Misses $0.43 Estimate, Sales $313.67M Miss $612.20M Estimate
Vector Group (NYSE:VGR) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.43 by 39.53 percent. This is a 23.81 percent increase over earnings of $0.21 per share from the
Recap: Vector Group Q4 Earnings
Vector Group (NYSE:VGR) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Vector Group missed estimated earnings by 39.53%, reporting an EPS of $0.26 versus an estimate of $0.43.
Overview Of Value Stocks In The Consumer Defensive Sector
What Defines a Value Stock?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
63 Biggest Movers From Yesterday
Gainers
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors.
Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Future FinTech Shares Spike Higher
Toward the end of Thursday, the Dow traded up 0.08% to 36,517.50 while the NASDAQ rose 0.46% to 15,838.04. The S&P also rose, gaining 0.12% to 4,798.69.
44 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors.
Mid-Day Market Update: Crude Oil Rises 0.5%; Integrated Media Technology Shares Jump
Midway through trading Thursday, the Dow traded up 0.04% to 36,504.54 while the NASDAQ rose 0.59% to 15,859.87. The S&P also rose, gaining 0.14% to 4,799.86.